Versant Capital Management, Inc Bristol Myers Squibb CO Transaction History

Versant Capital Management, Inc

$431 Million
Q3 2024

A detailed history of Versant Capital Management, Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Versant Capital Management, Inc holds 68,998 shares of BMY stock, worth $3.99 Million. This represents 0.83% of its overall portfolio holdings.

Number of Shares

68,998

Previous 68,612 0.56%

Holding current value

$3.99 Million

Previous $2.85 Million 25.31%

% of portfolio

0.83%

Previous 0.73%

34 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 07, 2024	BUY	$39.66 - $51.75 $15,308 - $19,975	386 Added 0.56%	68,998 $3.57 Million
Q2 2024 Jul 05, 2024	BUY	$40.25 - $52.99 $7,084 - $9,326	176 Added 0.26%	68,612 $2.85 Million
Q1 2024 Apr 03, 2024	SELL	$47.98 - $54.4 $44,045 - $49,939	-918 Reduced 1.32%	68,436 $3.71 Million
Q4 2023 Jan 08, 2024	SELL	$48.48 - $57.85 $6,011 - $7,173	-124 Reduced 0.18%	69,354 $3.56 Million
Q3 2023 Oct 11, 2023	BUY	$57.89 - $64.73 $1,447 - $1,618	25 Added 0.04%	69,478 $4.03 Million
Q2 2023 Jul 10, 2023	BUY	$63.71 - $70.74 $1,720 - $1,909	27 Added 0.04%	69,453 $4.44 Million
Q1 2023 Apr 10, 2023	BUY	$65.71 - $74.53 $60,321 - $68,418	918 Added 1.34%	69,426 $4.81 Million
Q4 2022 Jan 25, 2023	SELL	$68.48 - $81.09 $32,870 - $38,923	-480 Reduced 0.7%	68,508 $0
Q2 2022 Aug 02, 2022	SELL	$72.62 - $79.98 $1,089 - $1,199	-15 Reduced 0.02%	68,988 $5.31 Million
Q1 2022 Apr 29, 2022	SELL	$61.48 - $73.72 $737 - $884	-12 Reduced 0.02%	69,003 $5.04 Million
Q4 2021 Jan 06, 2022	SELL	$53.63 - $62.52 $321 - $375	-6 Reduced 0.01%	69,015 $4.3 Million
Q3 2021 Oct 29, 2021	SELL	$59.17 - $69.31 $831,930 - $974,498	-14,060 Reduced 16.92%	69,021 $4.08 Million
Q2 2021 Jul 22, 2021	SELL	$61.91 - $67.42 $309 - $337	-5 Reduced 0.01%	83,081 $5.55 Million
Q4 2020 Feb 08, 2021	SELL	$57.74 - $65.43 $173 - $196	-3 Reduced -0.0%	83,086 $5.15 Million
Q3 2020 Nov 02, 2020	BUY	$57.43 - $63.64 $631 - $700	11 Added 0.01%	83,089 $5.01 Million
Q2 2020 Jul 16, 2020	SELL	$54.82 - $64.09 $493 - $576	-9 Reduced 0.01%	83,078 $4.88 Million
Q1 2020 Apr 17, 2020	SELL	$46.4 - $67.43 $6,867 - $9,979	-148 Reduced 0.18%	83,087 $4.63 Million
Q4 2019 Jan 28, 2020	BUY	$49.21 - $64.19 $8,513 - $11,104	173 Added 0.21%	83,235 $5.34 Million
Q3 2019 Oct 18, 2019	BUY	$42.77 - $50.71 $2,224 - $2,636	52 Added 0.06%	83,062 $4.21 Million
Q2 2019 Jul 16, 2019	SELL	$44.62 - $49.34 $36,543 - $40,409	-819 Reduced 0.98%	83,010 $3.76 Million
Q1 2019 Apr 23, 2019	BUY	$45.12 - $53.8 $3.6 Million - $4.29 Million	79,830 Added 1996.25%	83,829 $4 Million
Q1 2019 Apr 23, 2019	SELL	$45.12 - $53.8 $3.66 Million - $4.36 Million	-81,040 Reduced 95.3%	3,999 $4 Million
Q3 2018 Oct 15, 2018	SELL	$55.19 - $62.25 $2,869 - $3,237	-52 Reduced 0.06%	85,039 $5.28 Million
Q2 2018 Jul 06, 2018	SELL	$50.53 - $62.98 $3,486 - $4,345	-69 Reduced 0.08%	85,091 $4.71 Million
Q1 2018 Apr 19, 2018	SELL	$59.92 - $68.98 $50,093 - $57,667	-836 Reduced 0.97%	85,160 $5.39 Million
Q4 2017 Apr 19, 2018	BUY	$59.94 - $65.35 $29,970 - $32,674	500 Added 0.58%	85,996 $5.27 Million
Q3 2017 Apr 23, 2018	SELL	$55.23 - $63.74 $3,258 - $3,760	-59 Reduced 0.07%	85,496 $5.45 Million
Q2 2017 Apr 23, 2018	SELL	N/A	-84 Reduced 0.1%	85,555 $4.77 Million
Q1 2017 Apr 23, 2018	BUY	N/A	106 Added 0.12%	85,639 $4.66 Million
Q4 2016 Apr 23, 2018	SELL	N/A	-232 Reduced 0.27%	85,533 $5 Million
Q3 2016 Apr 23, 2018	BUY	N/A	36 Added 0.04%	85,765 $4.62 Million
Q2 2016 Apr 23, 2018	BUY	N/A	5 Added 0.01%	85,729 $6.31 Million
Q1 2016 Apr 23, 2018	BUY	N/A	3 Added 0.0%	85,724 $5.48 Million
Q4 2015 Apr 23, 2018	BUY	N/A	85,721	85,721 $5.9 Million

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Versant Capital Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Versant Capital Management, Inc with notifications on news.

Account

Versant Capital Management, Inc Bristol Myers Squibb CO Transaction History